Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXL4SI
|
||||
Drug Name |
4-[(3,4-Difluorophenyl)methyl]-2-{[(2R)-1-methyl-2-pyrrolidinyl]methyl}-1(2H)-phthalazinone
|
||||
Synonyms |
CHEMBL1767149
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C21H21F2N3O
|
||||
Canonical SMILES |
CN1CCC[C@@H]1CN2N=C(Cc3ccc(F)c(F)c3)c4ccccc4C2=O
|
||||
InChI |
InChI=1S/C21H21F2N3O/c1-25-10-4-5-15(25)13-26-21(27)17-7-3-2-6-16(17)20(24-26)12-14-8-9-18(22)19(23)11-14/h2-3,6-9,11,15H,4-5,10,12-13H2,1H3/t15-/m1/s1
|
||||
InChIKey |
GFOPLENUCATIPC-OAHLLOKOSA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.